About Aktinos Pharma Private Limited
Data last updated:
Aktinos Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 13 September 2007.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2007PTC055510. Its GSTIN is 36AAGCA6198J1Z7 (Telangana). The company held 4 GST registrations, of which 2 are active.
The company had an authorised share capital of ₹20 Cr and a paid-up capital of ₹4.03 Cr. It was led by directors including Murali Krishna Madala (Managing Director) and Srilakshmi Madala (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹207.85 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net loss of ₹7.16 Cr (net margin -3.4%) and EBITDA of ₹7.12 Cr (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over five years.
The company had about 411 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Aktinos Pharma. As per MCA filings, the company had satisfied charges of ₹50.36 Cr on record. Court records list 7 cases involving the company, including 5 filed by the company and 2 filed against it; 4 cases are pending. The company has 13 deals on record (8 funding rounds, 5 secondary share transfers), with disclosed funding of ₹26.28 Cr; the latest was in April 2022. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Loxim Industries Limited with revenue of ₹227.28 Cr. The company has 13 MSME Form 1 returns on record between 2019 and 2023, listing 3,355 overdue payments to 147 micro and small suppliers.
The last known website on record is aktinos.in.
Company details
CIN history
Aktinos Pharma has one previous CIN (Corporate Identification Number): U24232AP2007PTC055510. The current CIN is U24232TG2007PTC055510, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2007PTC055510 | Current |
| U24232AP2007PTC055510 | Previous |
Contact details
Aktinos Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is aktinos.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSri Lakshmi Spaces 5th Floor Plot No. 7 Block No. B Kavuri Hills Phase – I Mad, Hapur, Hyderabad, Telangana, India – 500033
- IndustryPharma, API Manufacturers
To see the full contact details of Aktinos Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aktinos Pharma operates one associated brand: Aktinos Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers integrated scientific services for R&D and manufacturing in pharmaceuticals sector. | aktinos.in |
Business activity
The main business activity of Aktinos Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aktinos Pharma Private Limited, buy the company report.
Financials of Aktinos Pharma Private Limited
FY 2024 filings availableAktinos Pharma Private Limited reported revenue of ₹207.85 Cr (up 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 18% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹207.85 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.12 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.16 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | -3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aktinos Pharma Private Limited, buy the company report.
Board of directors of Aktinos Pharma Private Limited
Aktinos Pharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srilakshmi Madala Also directs: Aktinos Biologics LLP, Agrinourix LLP | Whole-Time Director | 13 Sep 2007 | 19 Years 1 Months | As last reported |
| Murali Krishna Madala Also directs: Apicore Pharmaceuticals Private Limited, 4C Drug Safety Services LLP, Aktinos Biologics LLP and 1 more | Managing Director | 13 Sep 2007 | 19 Years 1 Months | As last reported |
| Ravishanker Kovi Also directs: Trominosoft LLP, Apicore Pharmaceuticals Private Limited | Director | 24 Jul 2017 | 9 Years 3 Months | As last reported |
| Vineeth Madala | Director | 01 Aug 2022 | 4 Years 3 Months | As last reported |
Peer comparison
Aktinos Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Loxim Industries Limited | ₹227.28 Cr (FY 2025) | 26.0% | Ahmedabad, Gujarat, India | |||
| Akums Lifesciences Limited | ₹222.57 Cr (FY 2023) | 60.0% | Chandigarh, India | |||
| Vardhman Chemtech Limited | ₹208.69 Cr (FY 2025) | -13.0% | Chandigarh, India | |||
| Aktinos Pharma Private Limitedthis company | ₹207.85 Cr (FY 2024) | -₹7.16 Cr | -3.4% | 18.0% | 411 | Hyderabad, Telangana, India |
| Nifty Labs Private Limited | ₹206.98 Cr (FY 2025) | 30.0% | Aran Road, Ameerpet, Hyd-016, Telangana, India | |||
| Inogent Laboratories Private Limited | ₹206.9 Cr (FY 2017) | 18.0% | Hyderabad, Telangana, India | |||
| Smilax Laboratories Limited | ₹206.57 Cr (FY 2025) | -25.0% | Hyderabad, Telangana, India | |||
| Swati Spentose Private Limited | ₹205.55 Cr (FY 2024) | 11.0% | Mumbai, Maharashtra, India | |||
| Sharon Bio-Medicine Limited | ₹204.22 Cr (FY 2025) | -20.0% | Panvel, Maharashtra, India |
To see the full peer comparison of Aktinos Pharma Private Limited, buy the company report.
Auditor
Aktinos Pharma Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2023 | 012754N/N500016 |
Shareholding
The shareholding of Aktinos Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aktinos Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Feb 2023 | 100695749 | Others | ₹1.71 Cr | Satisfied | |
| 28 Feb 2022 | 100559027 | Others | ₹1.38 Cr | Satisfied | |
| 22 Apr 2021 | 100443999 | Others | ₹5 Cr | Satisfied | |
| 03 Apr 2017 | 100094654 | Axis Bank Limited | ₹16.32 Cr | Satisfied | |
| 02 Jul 2012 | 10372703 | Others | ₹17.75 Cr | Satisfied |
To see the full charge records of Aktinos Pharma Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Aktinos Pharma Private Limited has 13 deals on record (8 funding rounds, 5 secondary share transfers), with disclosed funding of ₹26.28 Cr; the latest was in April 2022.
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2022 | Funding round | ₹3.74 Cr | Investors: RK Pharma Inc |
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: RK Pharma Inc Seller: an individual |
| Oct 2019 | Secondary share transfer | Undisclosed | Buyer: RK Pharma Inc Seller: an individual |
| Mar 2018 | Funding round | ₹19.5 Cr | Investors: RK Pharma Inc |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
To see the full deal history of Aktinos Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Aktinos Pharma Private Limited has 7 court cases on record: 5 filed by Aktinos Pharma, 2 filed against it. 4 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 2 |
| District courts | 2 | 2 | 2 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by S Amit Speciality Chemicals Private Limited Through Kunjumon George | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Mithila Rasayan Private Limited | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against individuals | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against individuals | Pending |
To see the full case history of Aktinos Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Aktinos Pharma Private Limited was last rated by Icra on 12 Feb 2018.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 12 Feb 2018 |
To see the full credit ratings and regulatory alerts of Aktinos Pharma Private Limited, buy the company report.
MSME payment delays
Aktinos Pharma Private Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 3,355 overdue payments to 147 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 147)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Lab Needs Private Limited | |||
| Sai Siri Packaging | |||
| an individual supplier | |||
| Steelcity Trading Company | |||
| Sri Bhargavi Ammonia & Chemicals Private Limited |
To see the full MSME payment records of Aktinos Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Aktinos Pharma Private Limited has a workforce of 411 employees on its EPFO records as of Mar 30, 2024, across 2 active EPFO establishments.
GST
Aktinos Pharma has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCA6198J1Z7 | Telangana | Active | 01 Jul 2017 |
| 37AAGCA6198J3Z3 | Andhra Pradesh | Active | 25 Apr 2018 |
To see the full GST registrations and return filing status of Aktinos Pharma Private Limited, buy the company report.
Recent activity
Aktinos Pharma Private Limited has 9 board changes on record since 2007: 4 appointments and 5 cessations. The latest: Vineeth Madala ceased to be Whole-Time Director on 31 Aug 2023.
16 earlier events are in the company report.
Frequently asked questions
Aktinos Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Aktinos Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 13 September 2007 and is registered under CIN U24232TG2007PTC055510. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Aktinos Pharma was incorporated on 13 September 2007. It is registered with the Registrar of Companies, Hyderabad.
Aktinos Pharma had 4 directors:
- Murali Krishna Madala - Managing Director
- Srilakshmi Madala - Whole-Time Director
- Ravishanker Kovi - Director
- Vineeth Madala - Director
The CIN (Corporate Identification Number) of Aktinos Pharma is U24232TG2007PTC055510. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Aktinos Pharma is at Sri Lakshmi Spaces 5th Floor Plot No. 7 Block No. B Kavuri Hills Phase – I Mad, Hapur, Hyderabad, Telangana, India – 500033.
Aktinos Pharma can be reached through the website aktinos.in. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Aktinos Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 December 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Aktinos Pharma is 36AAGCA6198J1Z7, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 37AAGCA6198J3Z3 (Andhra Pradesh).
Aktinos Pharma operated in the pharma industry, in the api manufacturers segment.
Aktinos Pharma has 13 deals on record (8 funding rounds, 5 secondary share transfers), with disclosed funding of ₹26.28 Cr; the latest was in April 2022.
The peers of Aktinos Pharma by revenue are Loxim Industries Limited, Akums Lifesciences Limited, Vardhman Chemtech Limited, Nifty Labs Private Limited, Inogent Laboratories Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
